clinical trial · NCT06627244
Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
University of Miami·phase2·recruiting·n = 30
Metastatic Uveal MelanomaMetastatic Uveal Melanoma in the LiverTebentafuspTheraSphere™ Yttrium-90 Trans-Arterial Radioembolization
brief summary
The purpose of this study is to determine the effects (good and bad) that Tebentafusp in combination with Yttrium-90 (Y-90) radioembolization has on patients with metastatic uveal melanoma that has spread to the liver.
started
Feb 14, 2025
primary completion
Feb 17, 2028
completion
Feb 17, 2031
last updated
Feb 23, 2026
official title
Phase 2, Single Arm Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol